Literature DB >> 22386609

Total hip arthroplasty in adolescents with severe hip arthropathy and dysplasia associated with camptodactyly-arthropathy-coxa vara-pericarditis syndrome.

Joshua M Murphy1, Kelly L Vanderhave, Andrew G Urquhart.   

Abstract

Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome is a rare disorder. Patients with this syndrome experience early symptomatic arthropathy of the hips. We report a case of adolescent siblings with bilateral arthropathy associated with CACP syndrome in which total hip arthroplasty was performed as treatment of severe associated disability. Postoperative Harris Hip Scores for patient 1 were 86 for the right at 18 months and 96 for the left at 12 months. Postoperative Harris Hip Score at 6 months for patient 2 was 53; however, he had good range of motion and lacked deformity. Based on our limited experience and the limited available clinical data, we feel that total hip arthroplasty is a reasonable treatment option for adolescents with debilitating hip arthropathy associated with CACP syndrome.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22386609     DOI: 10.1016/j.arth.2012.01.007

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  Monogenic disorders as mimics of juvenile idiopathic arthritis.

Authors:  Laura Furness; Phil Riley; Neville Wright; Siddharth Banka; Stephen Eyre; Adam Jackson; Tracy A Briggs
Journal:  Pediatr Rheumatol Online J       Date:  2022-06-18       Impact factor: 3.413

2.  The Efficacy of Yttrium-90 Radiosynovectomy in Patients with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome.

Authors:  Sulaiman Mohammed Al-Mayouf; Nora Almutairi; Khalid Alismail
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05

3.  Protein-losing enteropathy in camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Bram Peters; Janneke H M Schuurs-Hoeijmakers; Joris Fuijkschot; Annette Reimer; Michiel van der Flier; Dorien Lugtenberg; Esther P A H Hoppenreijs
Journal:  Pediatr Rheumatol Online J       Date:  2016-05-25       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.